SCHEMBL10603264

SCHEMBL10603264

C#C[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.72
▸ ABCB11 O95342 4/20 0.72
▸ PGR P06401 4/20 0.72
▸ LMNA P02545 4/20 0.72
▸ CYP2C19 P33261 3/20 0.72
▸ NR3C1 P04150 3/20 0.72
▸ SLC6A4 P31645 3/20 0.72
▸ ESR1 P03372 2/20 0.72
▸ SHBG P04278 2/20 0.72
▸ TSHR P16473 1/20 0.72
▸ HIF1A Q16665 1/20 0.72
▸ ALDH1A1 P00352 1/20 0.72
▸ ADRA2A P08913 1/20 0.72
▸ AR P10275 3/20 0.70
▸ MEN1 O00255 3/20 0.70
▸ KMT2A Q03164 3/20 0.70
▸ MAPT P10636 2/20 0.70
▸ CHRM2 P08172 1/20 0.70
▸ ADORA3 P0DMS8 1/20 0.70
▸ CHRM1 P11229 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24476298 0.93 CYP3A4 (0.73) CYP3A4ABCB11PGRLMNACYP2C19
SCHEMBL24476410 0.90 CYP3A4 (0.69) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL37531 0.84 CYP3A4 (0.92) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL14577661 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL23390 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL6834811 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL7768886 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL24476231 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL14074493 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19
Norethindrone SCHEMBL11781372 0.84 CYP3A4 (1.00) CYP3A4ABCB11PGRLMNACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0152429-B1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1989-10-11 — — EP claimed
EP-0152429-A4 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-12-05 — — EP claimed
EP-0152429-A1 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-08-28 — — EP claimed
US-4512986-A FERTILITY CONTROL RESEARCH TRIANGLE INSTITUTE (US) 1985-04-23 — — US claimed
WO-1985000609-A1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1985-02-14 — — WO claimed
EP-0152429-B1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1989-10-11 — — EP disclosed
EP-0152429-A4 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-12-05 — — EP disclosed
EP-0152429-A1 PROGESTATIONALLY ACTIVE STEROIDS. RES TRIANGLE INST (US) 1985-08-28 — — EP disclosed
US-4512986-A FERTILITY CONTROL RESEARCH TRIANGLE INSTITUTE (US) 1985-04-23 — — US disclosed
WO-1985000609-A1 PROGESTATIONALLY ACTIVE STEROIDS RESEARCH TRIANGLE INSTITUTE (US) 1985-02-14 — — WO disclosed
Send feedback